- ICH GCP
- EU-register voor klinische proeven
Laatste proeven
EudraCT Number: 2004-000134-37 | Sponsor Protocol Number: 20010184 | Start Date: 2004-09-14 | |||||||||||
Sponsor Name: Amgen Inc. | |||||||||||||
Full Title: Trial to Reduce Cardiovascular Events with Aranesp Therapy | |||||||||||||
Medical condition: Treatment of anaemia in subjects with chronic kidney disease (CKD) amd Type 2 diabetes mellitus (DM) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) SK (Completed) CZ (Completed) LV (Completed) SE (Completed) IT (Completed) DK (Completed) GB (Completed) | |||||||||||||
Trial results: View results |